Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01659541 · ClinicalTrials.gov registry record · NA

Stimulation With Wire Leads to Restore Cough

A NA study of Spinal Cord Injuries and Wounds and Injuries, sponsored by MetroHealth Medical Center.

Completed
Registry status
NA
Development phase
12
Enrollment target
1
Study location

NCT01659541: Completed NA study of Spinal Cord Injuries and Wounds and Injuries, sponsored by MetroHealth Medical Center.

NCT01659541 is a NA study of Spinal Cord Injuries and Wounds and Injuries that has completed, run by MetroHealth Medical Center. The registered enrollment target is 12 participants, below the 62-participant average among 202 other Spinal Cord Injuries trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01659541, a NA study of Spinal Cord Injuries and Wounds and Injuries, has completed, sponsored by MetroHealth Medical Center.

COMPLETED
Registry status
NA
Development phase
12 participants
Enrollment target
1
Study location

Study Summary

The purpose of this trial is to determine the efficacy of spinal cord stimulation, using wire leads, to produce an effective cough in patients with spinal cord injuries.

Primary Outcome

Peak Expiratory airflow rate is a person's maximum speed of expiration. Peak expiratory flow rate is the maximum flow rate generated during a forceful exhalation, starting from full inspiration. It was measured after release of airway occlusion after peak airway pressure was achieved.

Interventions

  • DEVICE Expiratory muscle stimulator
  • PROCEDURE Implantation of device

Study Locations (1)

Ohio

  • MetroHealth Medical Center - Cleveland

Trial Details

FieldValue
Enrollment Target 12 participants
Start Date 2015-04
Est. Completion 2021-07-31
Phase NA
MetroHealth Medical Center

76 total trials

What the finished NCT01659541 record still lists

NCT01659541 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 62-participant average among 202 other Spinal Cord Injuries trials with a reported enrollment target (81% lower).

The record links to 7 conditions, with Spinal Cord Injuries appearing as the primary indexed condition, and to 2 interventions - of which Expiratory muscle stimulator is the first listed.

NCT01659541 reports a single indexed study location in Ohio.

Frequently Asked Questions

What is clinical trial NCT01659541 about?

NCT01659541 is a clinical study titled "Stimulation With Wire Leads to Restore Cough". The purpose of this trial is to determine the efficacy of spinal cord stimulation, using wire leads, to produce an effective cough in patients with spinal cord injuries.

What is the current status of trial NCT01659541?

This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2015-04. Estimated completion is 2021-07-31.

What conditions does trial NCT01659541 study?

This clinical trial studies the following conditions: Spinal Cord Injuries, Wounds and Injuries, Central Nervous System Diseases, Paralysis, Cough.

What interventions are being tested in trial NCT01659541?

The interventions under investigation include: Expiratory muscle stimulator (DEVICE), Implantation of device (PROCEDURE).

Who is sponsoring clinical trial NCT01659541?

This trial is sponsored by MetroHealth Medical Center, which has 76 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01659541 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Spinal Cord Injuries

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01659541's enrollment target sits among peer trials

12 165th of 202 higher than 30 of 202 other Spinal Cord Injuries trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Spinal Cord Injuries trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02602769 · 12 participants

    Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome

  • NCT02605421 · 12 participants · Phase 2

    Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma

  • NCT02619448 · 12 participants · Early Phase 1

    Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC

  • NCT03311503 · 12 participants · Phase 1

    Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01659541, the US trial registry maintained by the National Library of Medicine. NCT01659541 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.